Zydus

MAY 28, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Oxcarbazepine (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of oxcarbazepine labeling; this is a regulatory action, not a clinical evidence report, and does not contain trial outcomes or efficacy data.